Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0001649094-24-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-03 | 2024-10-01 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,500 | 34.1K | +19% | +$117.8K |
| DM | 2024-10-03 | 2024-10-01 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $114.24 | -5,500 | 32.7K | -14% | -$628.3K |
| D | 2024-10-03 | 2024-10-01 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $0.00 | -5,500 | 174.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | M | A | 5,500 | $21.41 | 34,123 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-01 | S | D | 3,056 | $114.37 | 29,653 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $113.83 to $114.82. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-10-01 | S | D | 1,030 | $115.01 | 28,623 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $114.95 to $115.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-10-01 | S | D | 1,414 | $113.38 | 32,709 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $112.795 to $113.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2024-10-01 | M | D | 5,500 | $0.00 | 174,497 | D | $21.41 · — to 2032-05-08 | 5,500 Common Stock | (F5) 1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |